These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20878119)

  • 1. Overexpression of BDNF and TrkB in human bladder cancer specimens.
    Lai PC; Chiu TH; Huang YT
    Oncol Rep; 2010 Nov; 24(5):1265-70. PubMed ID: 20878119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BDNF mediated TrkB activation is a survival signal for transitional cell carcinoma cells.
    Huang YT; Lai PC; Wu CC; Hsu SH; Cheng CC; Lan YF; Chiu TH
    Int J Oncol; 2010 Jun; 36(6):1469-76. PubMed ID: 20428771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
    Messing EM
    Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational studies of glutathione in bladder cancer cell lines and human specimens.
    Pendyala L; Velagapudi S; Toth K; Zdanowicz J; Glaves D; Slocum H; Perez R; Huben R; Creaven PJ; Raghavan D
    Clin Cancer Res; 1997 May; 3(5):793-8. PubMed ID: 9815751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P53 overexpression in bladder urothelial neoplasms: new aspect of World Health Organization/International Society of Urological Pathology classification.
    Kalantari MR; Ahmadnia H
    Urol J; 2007; 4(4):230-3. PubMed ID: 18270948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
    Zhou JT; Cai ZM; Li NC; Na YQ
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-1-3p inhibits cell proliferation and invasion by regulating BDNF-TrkB signaling pathway in bladder cancer.
    Gao L; Yan P; Guo FF; Liu HJ; Zhao ZF
    Neoplasma; 2018; 65(1):89-96. PubMed ID: 29322793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TrkB antibody elicits cytotoxicity and suppresses migration/invasion of transitional cell carcinoma cells.
    Huang YT; Lai PC; Wu CC; Cheng CC; Chiu TH
    Int J Oncol; 2010 Oct; 37(4):943-9. PubMed ID: 20811716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder.
    Li X; Choi WW; Yan R; Yu H; Krasnoperov V; Kumar SR; Schuckman A; Klumpp DJ; Pan CX; Quinn D; Gill IS; Gill PS; Liu R
    PLoS One; 2014; 9(8):e105326. PubMed ID: 25148033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.
    Elsamman E; Fukumori T; Kasai T; Nakatsuji H; Nishitani MA; Toida K; Ali N; Kanayama HO
    BJU Int; 2006 Jun; 97(6):1202-7. PubMed ID: 16686711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma.
    Sun W; Herrera GA
    Hum Pathol; 2002 Oct; 33(10):996-1000. PubMed ID: 12395372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The loss of expression of transforming growth factor-beta receptors correlates with the histopathologic tumor grade in bladder transitional cell carcinoma patients.
    Lee DH; Yang SC; Hong SJ; Chung BH; Chung HJ; Tokunaga H; Kim IY; Song YS; Lerner SP; Morton RA
    Yonsei Med J; 1999 Apr; 40(2):118-23. PubMed ID: 10333714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
    Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of transforming growth factor beta1 and its receptors in normal human urothelium and human transitional cell carcinomas.
    Izadifar V; de Boer WI; Muscatelli-Groux B; Maillé P; van der Kwast TH; Chopin DK
    Hum Pathol; 1999 Apr; 30(4):372-7. PubMed ID: 10208456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of human uroplakin Ia in urinary bladder transitional cell carcinoma.
    Kageyama S; Yoshiki T; Isono T; Tanaka T; Kim CJ; Yuasa T; Okada Y
    Jpn J Cancer Res; 2002 May; 93(5):523-31. PubMed ID: 12036448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THE SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR RECEPTOR AND SURVIVIN EXPRESSION IN BLADDER CANCER TISSUE AND URINE CYTOLOGY OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER.
    Kehinde EO; Al-Maghrebi M; Anim JT; Kapila K; George SS; Al-Juwaiser A; Memon A
    East Afr Med J; 2013 Jan; 90(1):19-27. PubMed ID: 26862626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of cyclooxygenase-2 in bladder transitional cell carcinoma and the significance thereof].
    Yu L; Chen XJ; Shi PQ; Ding Q; Sun CH; Liu GB; Shi DM; Huang YG
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2683-4. PubMed ID: 19080686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of vascular endothelial growth factor in transitional cell carcinoma of urinary bladder is correlated with cancer progression.
    Yang CC; Chu KC; Yeh WM
    Urol Oncol; 2004; 22(1):1-6. PubMed ID: 14969795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.
    Lazzeri M; Vannucchi MG; Spinelli M; Bizzoco E; Beneforti P; Turini D; Faussone-Pellegrini MS
    Eur Urol; 2005 Oct; 48(4):691-8. PubMed ID: 15992990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.